M. Confalonieri (Trieste, Italy), E. Bendstrup (Aarhus C, Denmark), G. Margaritopoulos (Kavala, Greece)
Sporadic and TSC-related lymphangioleiomyomatosis (LAM): The experience of Ospedale San Paolo of Milan (preliminary data)
G. Imeri, F. Di Marco, G. Palumbo, S. Terraneo, S. Centanni, F. Ribolla, G. F. Sferrazza Papa, G. Pellegrino, E. Rancati, E. M. Parazzini (Milan, Italy)
|   |
Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia
Y. Horimasu, N. Ishikawa, T. Nakashima, H. Iwamoto, T. Senoo, S. Ohshimo, K. Fujitaka, Y. Haruta, H. Murai, N. Hattori, N. Kohno (Hiroshima, Japan)
| |
Treatment of IPF with inhaled IFN-gamma; planning for a clinical trial
G. Smaldone, J. Yang, R. Condos (Stony Brook, New York, United States Of America)
| |
Pirfenidone therapy for patients with progressive idiopathic pulmonary fibrosis
F. Ihle, T. Veith, Z. Gregor, W. Gabriela, B. Juergen, N. Claus (Munich, Germany)
| |
Mindfulness-based stress reduction in patients with interstitial lung disease: A pilot study
G. Sgalla, R. Ferrari, S. Cerri, M. P. Ricchieri, M. Ori, M. Garuti, G. Montanari, S. Taddei, F. Luppi, R. Luca (Southampton, United Kingdom; Bologna, Modena, Italy)
| |
Protective effects of Dengzhanshengmai capsules on bleomycin-induced pulmonary fibrosis in mice
Y. Tan, Q. Zeng, H. Sun, D. Xiao (Guangzhou, China)
| |
Autophagy is not impaired in BALF alveolar macrophages in IPF: Preliminary results
S. Sarantoulaki, G. Margaritopoulos, E. Tsitoura, K. Karagiannis, E. Bibaki, A. Wells, N. Siafakas, G. Sourvinos, K. Antoniou (Heraklion, Greece)
| |
Late-onset non-infectious pulmonary complications after allogenic-stem cell transplant (LONIPC). Results of treatment strategy with multidisciplinary cooperation
M. Brunori, S. Melandri, S. K. Nkwenze, G. Pane, L. Panza, E. Pipitone, S. Ungaro, D. Parola (Rome, Italy)
| |
Pulmonary alveolar proteinosis – Gender differences in a 20 cases analysis in a reference institute in Romania
A. M. Nebunoiu, C. Tarasova, A. Serbescu, R. Stoica, G. Cadar, F. Mihaltan, O. C. Deleanu (Bucharest, Romania)
| |
Density gradient of the lung parenchyma at computed tomography in patients with pulmonary hypertension
M. Kokosi, G. J. Keir, B. Schreiber, J. Haddock, D. M. Hansell, A. U. Wells (London, United Kingdom)
| |
Changes in PH of exhaled breath condensate after specific inhalation challenge test, in patients with hypersensitivity pneumonitis
I. Ojanguren, M. J. Cruz, A. Villar, F. Morell, X. Muñoz (Barcelona, Spain)
| |
Long term follow-up of Greek patients with pulmonary sarcoidosis. Relation to transforming growth factor-beta genetic profile
D. Papakosta, G. Spyropoulos, K. Domvri, K. Manika, E. Kontakioti, K. Zarogoulidis (Exochi, Thessaloniki, Greece)
| |
Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF)
T. Takaiwa, H. Tachibana, M. Arita, T. Ishida (Kurashiki, Japan)
| |
Relation of cytokine expression profile of T-cells from blood and bronchoalveolar lavage fluid with HRCT pattern in fibrosing interstitial lung diseases
V. Polcova, M. Vasakova, M. Sterclova, P. Paluch, P. Mandakova, M. Paulik, Z. Khaznadar (Prague, Czech Republic)
| |
Safety and efficacy of pirfenidone in severe idiopathic pulmonary fibrosis
P. Ntolios, A. Koulelidis, G. Zacharis, A. Tzouvelekis, P. Boglou, K. Kaltsas, E. Bouros, T. Karampitsakos, M. Karailidou, P. Steiropoulos, M. Froudarakis, D. Bouros (Alexandroupolis, Greece)
| |
Fibroblast heterogeneity in the diseased lung
K. Heinzelmann, G. Preissler, H. Winter, R. Hatz, I. Koch, M. Lindner, J. Behr, O. Eickelberg (Munich, Gauting, Germany)
| |
Pulmonary hemodynamics and gasometric parameters associated with exercise induced oxygen desaturation in idiopathic pulmonary fibrosis
S. Hamdy, S. Mostafa (Assiut, Egypt)
| |
Homooligomerization of the ABC-transporter 3 and its functional significance
S. Frixel, E. Kaltenborn, A. S. Lotz-Havla, S. W. Gersting, R. Zarbock, M. Griese (Munich, Germany)
| |
Dissecting the role of TRPC6-channels in bleomycin-induced pulmonary fibrosis
K. Hofmann, V. Aumiller, O. Yildirim, T. Gudermann, M. Königshoff, A. Dietrich (Munich, Germany)
| |
The myofibroblast in pulmonary fibrosis displays distinct functional characteristics, depending on its source of origin
S. M. Walsh, D. A. Boylan, J. C. Worrell, R. V. Lumsden, R. Kane, M. P. Keane (Dublin, Ireland)
| |